A melanoma áttétképzésének klinikai jellemzoi

Translated title of the contribution: Clinical characteristics of melanoma metastasis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Approximately one third of clinical Stage I melanoma patients will experience disease recurrence. The author reviews the main prognostic factors predicting the outcome of melanoma patients, the incidence, pattern and time of first metastases. Of all recurrences, two third will occur earlier by the lymphatic, and one third later by the hematogenous pathway. 75-80% of recurrences develop in the first 3 years, 3-4% of metastases occur after 10 years of disease-free interval. The data emphasize the value of lifelong follow-up.

Original languageHungarian
Pages (from-to)85-88
Number of pages4
JournalMagyar Onkologia
Volume47
Issue number1
Publication statusPublished - 2003

Fingerprint

Melanoma
Neoplasm Metastasis
Recurrence
Incidence

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

A melanoma áttétképzésének klinikai jellemzoi. / Somlai, B.

In: Magyar Onkologia, Vol. 47, No. 1, 2003, p. 85-88.

Research output: Contribution to journalArticle

@article{3179e84e6f394a2ebb542e22354f6c77,
title = "A melanoma {\'a}tt{\'e}tk{\'e}pz{\'e}s{\'e}nek klinikai jellemzoi",
abstract = "Approximately one third of clinical Stage I melanoma patients will experience disease recurrence. The author reviews the main prognostic factors predicting the outcome of melanoma patients, the incidence, pattern and time of first metastases. Of all recurrences, two third will occur earlier by the lymphatic, and one third later by the hematogenous pathway. 75-80{\%} of recurrences develop in the first 3 years, 3-4{\%} of metastases occur after 10 years of disease-free interval. The data emphasize the value of lifelong follow-up.",
author = "B. Somlai",
year = "2003",
language = "Hungarian",
volume = "47",
pages = "85--88",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "1",

}

TY - JOUR

T1 - A melanoma áttétképzésének klinikai jellemzoi

AU - Somlai, B.

PY - 2003

Y1 - 2003

N2 - Approximately one third of clinical Stage I melanoma patients will experience disease recurrence. The author reviews the main prognostic factors predicting the outcome of melanoma patients, the incidence, pattern and time of first metastases. Of all recurrences, two third will occur earlier by the lymphatic, and one third later by the hematogenous pathway. 75-80% of recurrences develop in the first 3 years, 3-4% of metastases occur after 10 years of disease-free interval. The data emphasize the value of lifelong follow-up.

AB - Approximately one third of clinical Stage I melanoma patients will experience disease recurrence. The author reviews the main prognostic factors predicting the outcome of melanoma patients, the incidence, pattern and time of first metastases. Of all recurrences, two third will occur earlier by the lymphatic, and one third later by the hematogenous pathway. 75-80% of recurrences develop in the first 3 years, 3-4% of metastases occur after 10 years of disease-free interval. The data emphasize the value of lifelong follow-up.

UR - http://www.scopus.com/inward/record.url?scp=0041700210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041700210&partnerID=8YFLogxK

M3 - Article

C2 - 12704460

AN - SCOPUS:0041700210

VL - 47

SP - 85

EP - 88

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 1

ER -